![](https://endpts.com/wp-content/uploads/2023/08/GettyImages-1476119129-scaled.jpg)
Rainer Blair, Danaher president and CEO (Lintao Zhang/Getty Images)
Abcam agrees to $5.7B sale to Danaher amid founder's push for a board seat
Danaher will buy Abcam, a research tools supplier relied upon by many biopharmas, for an enterprise value of about $5.7 billion, the companies announced Monday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.